Key Points

  • PF4iCre;JAK2V617F/WT mice develop a full MPN that mimics polycythemia vera.

  • The PF4iCre system induces JAK2V617F mutation in a small subset of HSC.

Abstract

The major weakness of most knock-in JAK2V617F mouse models is the presence of the JAK2 mutation in all rather than in a few hematopoietic stem cells (HSC), such as in human “early-stage” myeloproliferative neoplasms (MPN). Understanding the mechanisms of disease initiation is critical as underscored by the incidence of clonal hematopoiesis of indeterminate potential associated with JAK2V617F. Currently, such studies require competitive transplantation. Here, we report a mouse model obtained by crossing JAK2V617F/WT knock-in mice with PF4iCre transgenic mice. As expected, PF4iCre;JAK2V617F/WT mice developed an early thrombocytosis resulting from the expression of JAK2V617F in the megakaryocytes. However, these mice then developed a polycythemia vera–like phenotype at 10 weeks of age. Using mT/mG reporter mice, we demonstrated that Cre recombination was present in all hematopoietic compartments, including in a low number of HSC. The frequency of mutated cells increased along hematopoietic differentiation mimicking the clonal expansion observed in essential thrombocythemia and polycythemia vera patients. This model thus mimics the HSC compartment observed in early-stage MPN, with a small number of JAK2V617F HSC competing with a majority of JAK2WT HSC. PF4iCre;JAK2V617F/WT mice are a promising tool to investigate the mechanisms that regulate clonal dominance and progression to myelofibrosis.

REFERENCES

REFERENCES
1.
Etheridge
SL
,
Roh
ME
,
Cosgrove
ME
, et al
.
JAK2V617F-positive endothelial cells contribute to clotting abnormalities in myeloproliferative neoplasms
.
Proc Natl Acad Sci U S A
.
2014
;
111
(
6
):
2295
-
2300
.
2.
Lamrani
L
,
Lacout
C
,
Ollivier
V
, et al
.
Hemostatic disorders in a JAK2V617F-driven mouse model of myeloproliferative neoplasm
.
Blood
.
2014
;
124
(
7
):
1136
-
1145
.
3.
Mullally
A
,
Lane
SW
,
Ball
B
.
Physiological Jak2V617F expression causes a lethal myeloproliferative neoplasm with differential effects on hematopoietic stem and progenitor cells
.
Cancer Cell
.
2010
;
17
(
6
):
584
-
596
.
4.
James
C
,
Mazurier
F
,
Dupont
S
, et al
.
The hematopoietic stem cell compartment of JAK2V617F-positive myeloproliferative disorders is a reflection of disease heterogeneity
.
Blood
.
2008
;
112
(
6
):
2429
-
2438
.
5.
Dupont
S
,
Massé
A
,
James
C
, et al
.
The JAK2 617V>F mutation triggers erythropoietin hypersensitivity and terminal erythroid amplification in primary cells from patients with polycythemia vera
.
Blood
.
2007
;
110
(
3
):
1013
-
1021
.
6.
McKerrell
T
,
Park
N
,
Moreno
T
, et al;
Understanding Society Scientific Group
.
Leukemia-associated somatic mutations drive distinct patterns of age-related clonal hemopoiesis
.
Cell Reports
.
2015
;
10
(
8
):
1239
-
1245
.
7.
Genovese
G
,
Kähler
AK
,
Handsaker
RE
, et al
.
Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence
.
N Engl J Med
.
2014
;
371
(
26
):
2477
-
2487
.
8.
Steensma
DP
.
Clinical consequences of clonal hematopoiesis of indeterminate potential
.
Blood Adv
.
2018
;
2
(
22
):
3404
-
3410
.
9.
Hasan
S
,
Lacout
C
,
Marty
C
, et al
.
JAK2V617F expression in mice amplifies early hematopoietic cells and gives them a competitive advantage that is hampered by IFNα
.
Blood
.
2013
;
122
(
8
):
1464
-
1477
.
10.
Tiedt
R
,
Schomber
T
,
Hao-Shen
H
,
Skoda
RC
.
Pf4-Cre transgenic mice allow the generation of lineage-restricted gene knockouts for studying megakaryocyte and platelet function in vivo
.
Blood
.
2007
;
109
(
4
):
1503
-
1506
.
11.
Muzumdar
MD
,
Tasic
B
,
Miyamichi
K
,
Li
L
,
Luo
L
.
A global double-fluorescent Cre reporter mouse
.
Genesis
.
2007
;
45
(
9
):
593
-
605
.
12.
Kilani
B
,
Gourdou-Latyszenok
V
,
Guy
A
, et al
.
Comparison of endothelial promoter efficiency and specificity in mice reveals a subset of Pdgfb-positive hematopoietic cells
.
J Thromb Haemost
.
2019
;
17
(
5
):
827
-
840
.
13.
Calaminus
SDJ
,
Guitart
AV
,
Sinclair
A
, et al
.
Lineage tracing of Pf4-Cre marks hematopoietic stem cells and their progeny
.
PLoS One
.
2012
;
7
(
12
):
e51361
.
14.
Nagy
Z
,
Vögtle
T
,
Geer
MJ
, et al
.
The Gp1ba-Cre transgenic mouse: a new model to delineate platelet and leukocyte functions
.
Blood
.
2019
;
133
(
4
):
331
-
343
.
15.
Zhan
H
,
Ma
Y
,
Lin
CHS
,
Kaushansky
K
.
JAK2V617F-mutant megakaryocytes contribute to hematopoietic stem/progenitor cell expansion in a model of murine myeloproliferation
.
Leukemia
.
2016
;
30
(
12
):
2332
-
2341
.
16.
Woods
B
,
Chen
W
,
Chiu
S
, et al
.
Activation of JAK/STAT signaling in megakaryocytes sustains myeloproliferation in vivo
.
Clin Cancer Res
.
2019
;
25
(
19
):
5901
-
5912
.
17.
Wernig
G
,
Mercher
T
,
Okabe
R
,
Levine
RL
,
Lee
BH
,
Gilliland
DG
.
Expression of Jak2V617F causes a polycythemia vera-like disease with associated myelofibrosis in a murine bone marrow transplant model
.
Blood
.
2006
;
107
(
11
):
4274
-
4281
.
18.
Zaleskas
VM
,
Krause
DS
,
Lazarides
K
, et al
.
Molecular pathogenesis and therapy of polycythemia induced in mice by JAK2 V617F
.
PLoS One
.
2006
;
1
(
1
):
e18
.
19.
Upadhaya
S
,
Sawai
CM
,
Papalexi
E
, et al
.
Kinetics of adult hematopoietic stem cell differentiation in vivo
.
J Exp Med
.
2018
;
215
(
11
):
2815
-
2832
.
20.
Notta
F
,
Zandi
S
,
Takayama
N
, et al
.
Distinct routes of lineage development reshape the human blood hierarchy across ontogeny
.
Science
.
2016
;
351
(
6269
):
aab2116
.
You do not currently have access to this content.